Cordis wins FDA approval for sirolimus-eluting balloon

Cordis wins FDA approval for sirolimus-eluting balloon is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-09-22

The approval gives physicians an alternative to uncoated balloons and Boston Scientific’s paclitaxel-coated device.

Source: MedTech Dive